Diagnostica Stago Inc - Product Pipeline Analysis, 2018 Update
[Updated: 25-10-2018]

Published by Global Data on 25th October 2018 | Ref: 1085913 | This Report Is In Stock

$750 | Single User
$1500 | Site License
$2250 | Enterprise License
$750 | Single User
$1500 | Site License
$2250 | Enterprise License

Introduction

Summary

Diagnostica Stago Inc (Stago), a subsidiary of Diagnostica Stago SAS, is a medical device company that develops and distributes in-vitro diagnostic products. The company develops coagulation automation systems. It provides products such as hemostasis analyzers, viscosity based detection systems, reagents and research products. Stago’s research and reagent products includes venoms, activators, purified proteins, coagulation factors, inhibitors, chromogenic substrates, lupus inhibitors, heparin anti-xa assays, coagulation inhibitors, fibrin and fibrinogen degradation products, among others. The company offers various customer services such as proficiency testing, field technical support, education and customer training. It also offers hemostasis proficiency testing program and peer group program. The company operates in the US and Canada. Stago is headquartered in Parsippany, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Diagnostica Stago Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Diagnostica Stago Inc Company Overview 5

Diagnostica Stago Inc Company Snapshot 5

Diagnostica Stago Inc Pipeline Products and Ongoing Clinical Trials Overview 5

Diagnostica Stago Inc – Pipeline Analysis Overview 7

Diagnostica Stago Inc - Key Facts 7

Diagnostica Stago Inc - Major Products and Services 8

Diagnostica Stago Inc Pipeline Products by Development Stage 9

Diagnostica Stago Inc Pipeline Products Overview 11

Calibrated Automated Thrombogram - Thrombin Assay 11

Calibrated Automated Thrombogram - Thrombin Assay Product Overview 11

STA Compact Max - Apixaban Calibrators And Controls 12

STA Compact Max - Apixaban Calibrators And Controls Product Overview 12

STA Compact Max - Dabigatran Calibrator And Control 13

STA Compact Max - Dabigatran Calibrator And Control Product Overview 13

STA Compact Max - Edoxaban Calibrator And Control 14

STA Compact Max - Edoxaban Calibrator And Control Product Overview 14

STA Compact Max - NeoPTimal ISI 15

STA Compact Max - NeoPTimal ISI Product Overview 15

STA Compact Max - Ristocetin Cofactor Assay 16

STA Compact Max - Ristocetin Cofactor Assay Product Overview 16

STA Compact Max - Rivaroxaban Calibrators And Controls For Anti-Xa 17

STA Compact Max - Rivaroxaban Calibrators And Controls For Anti-Xa Product Overview 17

STA-R Evolution Expert - Automated Ecarin Chromogenic Assay 18

STA-R Evolution Expert - Automated Ecarin Chromogenic Assay Product Overview 18

STA-R Evolution Expert - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa 19

STA-R Evolution Expert - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa Product Overview 19

STA-R Evolution Plus - Automated Ecarin Chromogenic Assay 20

STA-R Evolution Plus - Automated Ecarin Chromogenic Assay Product Overview 20

STA-R Evolution Plus - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa 21

STA-R Evolution Plus - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa Product Overview 21

STA-R Max - Apixaban Calibrators And Controls 22

STA-R Max - Apixaban Calibrators And Controls Product Overview 22

STA-R Max - Dabigatran Calibrator And Control 23

STA-R Max - Dabigatran Calibrator And Control Product Overview 23

STA-R Max - Edoxaban Calibrator And Control 24

STA-R Max - Edoxaban Calibrator And Control Product Overview 24

STA-R Max - NeoPTimal ISI 25

STA-R Max - NeoPTimal ISI Product Overview 25

STA-R Max - Ristocetin Cofactor Assay 26

STA-R Max - Ristocetin Cofactor Assay Product Overview 26

STA-R Max - Rivaroxaban Calibrators And Controls For Anti-Xa 27

STA-R Max - Rivaroxaban Calibrators And Controls For Anti-Xa Product Overview 27

Diagnostica Stago Inc - Key Competitors 28

Diagnostica Stago Inc - Key Employees 29

Diagnostica Stago Inc - Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Recent Developments 31

Diagnostica Stago Inc, Recent Developments 31

Sep 16, 2014: Stago’s D-Dimer test, 1st assay to meet the new CLSI H59-A standards for exclusion of PE 31

Aug 18, 2009: Diagnostica Stago Opens New Training Center 31

May 04, 2009: Instrumentation Laboratory Wins Patent Infringement And Unfair Competition Trial Against Diagnostica Stago Relating To Reagents For Hemostasis Diagnostics 31

Appendix 33

Methodology 33

About GlobalData 36

Contact Us 36

Disclaimer 36

Additional Details

Publisher

Global Data

Publisher Information

Reference

1085913 | GDME1012PD

Number of Pages

36

Report Format

PDF

This report is published by Global Data

Download Free Report Summary PDF

Diagnostica Stago Inc - Product Pipeline Analysis, 2018 Update [Updated: 25-10-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.